Functional characterization of putative cholesterol binding sequence (CRAC) in human type-1 cannabinoid receptor

Journal of Neurochemistry

Volumn 116, Issue 5, 2011, Pages 858-865

  Oddi, Sergio ^a,b   Dainese, Enrico ^a   Fezza, Filomena ^b,c   Lanuti, Mirko ^a,b   Barcaroli, Daniela ^d   De Laurenzi, Vincenzo ^d   Centonze, Diego ^b,c   MacCarrone, Mauro ^a,b  

^a UNIVERSITY OF TERAMO   (Italy)

^b IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

^d UNIVERSITY OF CHIETI   (Italy)

Author keywords

cannabinoid receptor; cholesterol; CRAC; FRAP; mutagenesis

Indexed keywords

CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CHOLESTEROL; GLYCINE; LYSINE;

AMINO ACID SEQUENCE; ARTICLE; ASTROCYTE; CELL MEMBRANE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; INTRACELLULAR MEMBRANE; MUTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION;

AMINO ACID SEQUENCE; CELL LINE, TUMOR; CELL MEMBRANE; CHOLESTEROL; CONSENSUS SEQUENCE; CYCLIC AMP; EXTRACELLULAR FLUID; GLYCINE; GREEN FLUORESCENT PROTEINS; HUMANS; LYSINE; MODELS, MOLECULAR; MUTATION; NEUROBLASTOMA; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RECEPTOR, CANNABINOID, CB1; TRANSFECTION;

EID: 79851494039     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2010.07041.x     Document Type: Article

References (45)

1. Barak L. S., Ferguson S. S., Zhang J., Martenson C., Meyer T., and, Caron M. G., (1997) Internal trafficking and surface mobility of a functionally intact beta2-adrenergic receptor-green fluorescent protein conjugate. Mol. Pharmacol. 51, 177-184. (Pubitemid 27074137)
2. Bari M., Paradisi A., Pasquariello N., and, Maccarrone M., (2005a) Cholesterol-dependent modulation of type 1 cannabinoid receptors in nerve cells. J. Neurosci. Res. 81, 275-283. (Pubitemid 41153342)
3. Bari M., Battista N., Fezza F., Finazzi-Agràí A., and, Maccarrone M., (2005b) Lipid rafts control signaling of type-1 cannabinoid receptors in neuronal cells. Implications for anandamide-induced apoptosis. J. Biol. Chem. 280, 12212-12220.
4. Bari M., Spagnuolo P., Fezza F., Oddi S., Pasquariello N., Finazzi-Agràí A., and, Maccarrone M., (2006) Effect of lipid rafts on Cb2 receptor signaling and 2-arachidonoyl-glycerol metabolism in human immune cells. J. Immunol. 177, 4971-4980. (Pubitemid 44527566)
5. Bari M., Oddi S., De Simone C., Spagnolo P., Gasperi V., Battista N., Centonze D., and, Maccarrone M., (2008) Type-1 cannabinoid receptors colocalize with caveolin-1 in neuronal cells. Neuropharmacology 54, 45-50. (Pubitemid 350299413)
6. Bisogno T., and, Di Marzo V., (2010) Cannabinoid receptors and endocannabinoids: role in neuroinflammatory and neurodegenerative disorders. CNS Neurol. Disord. Drug Targets 9, 564-573.
7. Boesze-Battaglia K., and, Albert A. D., (1990) Cholesterol modulation of photoreceptor function in bovine retinal rod outer segments. J. Biol. Chem. 265, 20727-20730. (Pubitemid 120014069)
8. Bouaboula M., Perrachon S., Milligan L., et al. (1997) A selective inverse agonist for central cannabinoid receptor inhibits mitogen-activated protein kinase activation stimulated by insulin or insulin-like growth factor 1. Evidence for a new model of receptor/ligand interactions. J. Biol. Chem. 272, 22330-22339. (Pubitemid 27382869)
9. Dainese E., Oddi S., Bari M., and, Maccarrone M., (2007) Modulation of the endocannabinoid system by lipid rafts. Curr. Med. Chem. 14, 2702-2715. (Pubitemid 350048324)
10. Dainese E., Oddi S., and, Maccarrone M., (2010) Interaction of endocannabinoid receptors with biological membranes. Curr. Med. Chem. 17, 1487-1499.
11. Di Marzo V., (2008) Targeting the endocannabinoid system: to enhance or reduce? Nat. Rev. Drug. Discov. 7, 438-455. (Pubitemid 351649182)
12. Ellis J., Pediani J. D., Canals M., Milasta S., and, Milligan G., (2006) Orexin-1 receptor-cannabinoid CB1 receptor heterodimerization results in both ligand-dependent and -independent coordinated alterations of receptor localization and function. J. Biol. Chem. 281, 38812-38824. (Pubitemid 46042008)
13. Epand R. M., (2006) Cholesterol and the interaction of proteins with membrane domains. Prog. Lipid Res. 45, 279-294. (Pubitemid 43818129)
14. Epand R. M., Sayer B. G., and, Epand R. F., (2005) Caveolin scaffolding region and cholesterol-rich domains in membranes. J. Mol. Biol. 345, 339-350. (Pubitemid 39574855)
15. Ganguly S., Pucadyil T. J., and, Chattopadhyay A., (2008) Actin cytoskeleton-dependent dynamics of the human serotonin1A receptor correlates with receptor signaling. Biophys. J. 95, 451-463.
16. Guex N., and, Peitsch M. C., (1997) SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis 18, 2714-2723. (Pubitemid 28059943)
17. Hagmann J., and, Fishman P. H., (1982) Detergent extraction of cholera toxin and gangliosides from cultured cells and isolated membranes. Biochim. Biophys. Acta 720, 181-187. (Pubitemid 12127701)
18. Howlett A. C., Blume L. C., and, Dalton G. D., (2010) CB(1) cannabinoid receptors and their associated proteins. Curr. Med. Chem. 17, 1382-1393.
19. Jamin N., Neumann J. M., Ostuni M. A., Vu T. K., Yao Z. X., Murail S., Robert J. C., Giatzakis C., Papadopoulos V., and, Lacapere J. J., (2005) Characterization of the cholesterol recognition amino acid consensus sequence of the peripheral-type benzodiazepine receptor. Mol. Endocrinol. 19, 588-594. (Pubitemid 40349433)
20. Kalipatnapu S., and, Chattopadhyay A., (2004) A GFP fluorescence-based approach to determine detergent insolubility of the human serotonin1A receptor. FEBS Lett. 576, 455-460. (Pubitemid 39388645)
21. Katona I., and, Freund T. F., (2008) Endocannabinoid signaling as a synaptic circuit breaker in neurological disease. Nat. Med. 14, 923-930.
22. Kwik J., Boyle S., Fooksman D., Margolis L., Sheetz M. P., and, Edidin M., (2003) Membrane cholesterol, lateral mobility, and the phosphatidylinositol 4, 5-bisphosphate-dependent organization of cell actin. Proc. Natl Acad. Sci. USA 100, 13964-13969. (Pubitemid 37499174)
23. Leterrier C., Bonnard D., Carrel D., Rossier J., and, Lenkei Z., (2004) Constitutive endocytic cycle of the CB1 cannabinoid receptor. J. Biol. Chem. 279, 36013-36021. (Pubitemid 39100609)
24. Li H., and, Papadopoulos V., (1998) Peripheral-type benzodiazepine receptor function in cholesterol transport. Identification of a putative cholesterol recognition/interaction amino acid sequence and consensus pattern. Endocrinology 139, 4991-4997. (Pubitemid 28533447)
25. Li Q., Lau A., Morris T. J., Guo L., Fordyce C. B., and, Stanley E. F., (2004) A syntaxin 1, Galpha(o), and N-type calcium channel complex at a presynaptic nerve terminal: analysis by quantitative immunocolocalization. J. Neurosci. 24, 4070-4081. (Pubitemid 38544233)
26. Maccarrone M., Battista N., and, Centonze D., (2007) The endocannabinoid pathway in Huntington's disease: a comparison with other neurodegenerative diseases. Prog. Neurobiol. 81, 349-379. (Pubitemid 46528640)
27. Manders E. M. M., Verbeek F. J., and, Aten J. A., (1993) Measurement of co-localization of objects in dual-colour confocal images. J. Microsc. 169, 375-382. (Pubitemid 23119681)
28. Osborne K. D., Lee W., Malarkey E. B., Irving A. J., and, Parpura V., (2009) Dynamic imaging of cannabinoid receptor 1 vesicular trafficking in cultured astrocytes. ASN Neuro. 1, 283-296.
29. Paila Y. D., and, Chattopadhyay A., (2009) The function of G-protein coupled receptors and membrane cholesterol: specific or general interaction? Glycoconj. J. 26, 711-720.
30. Paila Y. D., Ganguly S., and, Chattopadhyay A., (2010) Metabolic depletion of sphingolipids impairs ligand binding and signaling of human serotonin1A receptors. Biochemistry 49, 2389-2397.
31. Palczewski K., Kumasaka T., Hori T., et al. (2000) Crystal structure of rhodopsin: A G protein-coupled receptor. Science 289, 739-745. (Pubitemid 30650186)
32. Pasquariello N., Catanzaro G., Marzano V., Amadio D., Barcaroli D., Oddi S., Federici G., Urbani A., Finazzi-Agràí A., and, Maccarrone M., (2009) Characterization of the endocannabinoid system in human neuronal cells and proteomic analysis of anandamide-induced apoptosis. J. Biol. Chem. 284, 29413-29426.
33. Piomelli D., (2003) The molecular logic of endocannabinoid signalling. Nat. Rev. Neurosci. 4, 873-884. (Pubitemid 37351427)
34. Pontier S. M., Percherancier Y., Galandrin S., Breit A., Gales C., and, Bouvier M., (2008) Cholesterol-dependent separation of the beta2-adrenergic receptor from its partners determines signaling efficacy: insight into nanoscale organization of signal transduction. J. Biol. Chem. 283, 24659-24672.
35. Prinetti A., Loberto N., Chigorno V., and, Sonnino S., (2009) Glycosphingolipid behaviour in complex membranes. Biochim. Biophys. Acta 1788, 184-193.
36. Puertollano R., Martin-Belmonte F., Millan J., de Marco M. C., Albar J. P., Kremer L., and, Alonso M. A., (1999) The MAL proteolipid is necessary for normal apical transport and accurate sorting of the influenza virus hemagglutinin in Madin-Darby canine kidney cells. J. Cell Biol. 145, 141-151. (Pubitemid 29177681)
37. Rimmerman N., Hughes H. V., Bradshaw H. B., Pazos M. X., Mackie K., Prieto A. L., and, Walker J. M., (2008) Compartmentalization of endocannabinoids into lipid rafts in a dorsal root ganglion cell line. Br. J. Pharmacol. 153, 380-389.
38. Sarnataro D., Grimaldi C., Pisanti S., Gazzerro P., Laezza C., Zurzolo C., and, Bifulco M., (2005) Plasma membrane and lysosomal localization of CB1 cannabinoid receptor are dependent on lipid rafts and regulated by anandamide in human breast cancer cells. FEBS Lett. 579, 6343-6349. (Pubitemid 41612150)
39. Shrivastava S., Pucadyil T. J., Paila Y. D., Ganguly S., and, Chattopadhyay A., (2010) Chronic cholesterol depletion using statin impairs the function and dynamics of human serotonin(1A) receptors. Biochemistry 49, 5426-5435.
40. Thomsen P., Roepstorff K., Stahlhut M., and, van Deurs B., (2002) Caveolae are highly immobile plasma membrane microdomains, which are not involved in constitutive endocytic trafficking. Mol. Biol. Cell 13, 238-250. (Pubitemid 34106072)
41. Walmsley A. R., Zeng F., and, Hooper N. M., (2003) The N-terminal region of the prion protein ectodomain contains a lipid raft targeting determinant. J. Biol. Chem. 278, 37241-37248. (Pubitemid 37175240)
42. Wu D. F., Yang L. Q., Goschke A., Stumm R., Brandenburg L. O., Liang Y. J., Hollt V., and, Koch T., (2008) Role of receptor internalization in the agonist-induced desensitization of cannabinoid type 1 receptors. J. Neurochem. 104, 1132-1143. (Pubitemid 351143650)
43. Xiang Y., Rybin V. O., Steinberg S. F., and, Kobilka B., (2002) Caveolar localization dictates physiologic signaling of beta 2-adrenoceptors in neonatal cardiac myocytes. J. Biol. Chem. 277, 34280-34286.
44. Xie H. Q., Liang D., Leung K. W., Chen V. P., Zhu K. Y., Chan W. K., Choi R. C., Massoulie J., and, Tsim K. W., (2010) Targeting acetylcholinesterase to membrane rafts: a function mediated by the proline-rich membrane anchor (PRiMA) in neurons. J. Biol. Chem. 285, 11537-11546.
45. Xu W., Yoon S. I., Huang P., Wang Y., Chen C., Chong P. L., and, Liu-Chen L. Y., (2006) Localization of the kappa opioid receptor in lipid rafts. J. Pharmacol. Exp. Ther. 317, 1295-1306. (Pubitemid 43764136)